These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 8865445)

  • 21. Omeprazole versus high-dose ranitidine in mild gastroesophageal reflux disease: short- and long-term treatment. The Dutch Reflux Study Group.
    Festen HP; Schenk E; Tan G; Snel P; Nelis F
    Am J Gastroenterol; 1999 Apr; 94(4):931-6. PubMed ID: 10201459
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Double-blind crossover study of ranitidine and placebo in gastro-oesophageal reflux disease.
    Johansson KE; Boeryd B; Johansson K; Tibbling L
    Scand J Gastroenterol; 1986 Sep; 21(7):769-78. PubMed ID: 3535004
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Role of ranitidine in the treatment of gastroesophageal reflux and its complications].
    Mainguet P
    Rev Med Suisse Romande; 1995 Oct; 115(10):781-8. PubMed ID: 7501930
    [No Abstract]   [Full Text] [Related]  

  • 24. Natural history of gastro-oesophageal reflux disease without oesophagitis (NERD)--a reappraisal 10 years on.
    Pace F; Bollani S; Molteni P; Bianchi Porro G
    Dig Liver Dis; 2004 Feb; 36(2):111-5. PubMed ID: 15002817
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relapse prevention in reflux oesophagitis with regard to Helicobacter pylori status: a double-blind, randomized, multicentre trial to compare the efficacy of pantoprazole versus ranitidine.
    Adamek RJ; Behrendt J; Wenzel C
    Eur J Gastroenterol Hepatol; 2001 Jul; 13(7):811-7. PubMed ID: 11474311
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impaired egress rather than increased access: an important independent predictor of erosive oesophagitis.
    Jones MP; Sloan SS; Jovanovic B; Kahrilas PJ
    Neurogastroenterol Motil; 2002 Dec; 14(6):625-31. PubMed ID: 12464084
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effect of oxmetidine and ranitidine on reflux behavior in patients with esophagitis].
    Weiser HF; Gubernatis G; Siewert JR
    Z Gastroenterol; 1983 Oct; 21(10):580-4. PubMed ID: 6139923
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Onset of action of antisecretory drugs: beneficial effects of a rapid increase in intragastric pH in acid reflux disease.
    Pipkin GA; Mills JG
    Scand J Gastroenterol Suppl; 1999; 230():3-8. PubMed ID: 10499455
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lansoprazole compared with ranitidine for the treatment of nonerosive gastroesophageal reflux disease.
    Richter JE; Campbell DR; Kahrilas PJ; Huang B; Fludas C
    Arch Intern Med; 2000 Jun; 160(12):1803-9. PubMed ID: 10871974
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acute treatment of reflux oesophagitis: a multicentre study to compare 150 mg ranitidine twice daily with 300 mg ranitidine at bedtime.
    Halvorsen L; Lee FI; Wesdorp IC; Johnson NJ; Mills JG; Wood JR
    Aliment Pharmacol Ther; 1989 Apr; 3(2):171-81. PubMed ID: 2491468
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Standard-dose lansoprazole is more effective than high-dose ranitidine in achieving endoscopic healing and symptom relief in patients with moderately severe reflux oesophagitis. The Dutch Lansoprazole Study Group.
    Jansen JB; Van Oene JC
    Aliment Pharmacol Ther; 1999 Dec; 13(12):1611-20. PubMed ID: 10594396
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of ranitidine, given t.d.s., on intragastric and oesophageal pH in patients with gastrooesophageal reflux.
    Russell J; Orr WC; Wilson T; Finn AL
    Aliment Pharmacol Ther; 1991 Dec; 5(6):621-30. PubMed ID: 1782305
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gastric secretion and reflux pattern in reflux oesophagitis before and during ranitidine treatment.
    Johansson KE; Tibbling L
    Scand J Gastroenterol; 1986 May; 21(4):487-92. PubMed ID: 3523741
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevention of relapse in reflux esophagitis: a placebo controlled study of ranitidine 150 mg bid and 300 mg bid.
    Hegarty JH; Halvorsen L; Hazenberg BP; Nowak A; Smith CL; Thomson AB; Vantrappen G; McKenna CJ; Mills JG
    Can J Gastroenterol; 1997; 11(1):83-8. PubMed ID: 9113805
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Comparison of the effects of Rocgel and anti-H2 on the symptomatology of gastroesophageal reflux without esophagitis].
    Houcke P; Maffioli C; Corallo J; Bouxin-Sauzet A; Martin AL
    Ann Gastroenterol Hepatol (Paris); 1995 Sep; 31(4):264-7. PubMed ID: 7486823
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oesophagitis, signs of reflux, and gastric acid secretion in patients with symptoms of gastro-oesophageal reflux disease.
    Johansson KE; Ask P; Boeryd B; Fransson SG; Tibbling L
    Scand J Gastroenterol; 1986 Sep; 21(7):837-47. PubMed ID: 3775250
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pattern of acid reflux in patients with reflux esophagitis 'resistant' to H2-receptor antagonists.
    Bianchi Porro G; Pace F; Sangaletti O
    Scand J Gastroenterol; 1990 Aug; 25(8):810-4. PubMed ID: 1976270
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Omeprazole or high-dose ranitidine in the treatment of patients with reflux oesophagitis not responding to 'standard doses' of H2-receptor antagonists.
    Lundell L; Backman L; Ekström P; Enander LH; Fausa O; Lind T; Lönroth H; Sandmark S; Sandzén B; Unge P
    Aliment Pharmacol Ther; 1990 Apr; 4(2):145-55. PubMed ID: 1983321
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of Helicobacter pylori eradication on oesophageal acid exposure in patients with reflux oesophagitis.
    Wu JC; Chan FK; Wong SK; Lee YT; Leung WK; Sung JJ
    Aliment Pharmacol Ther; 2002 Mar; 16(3):545-52. PubMed ID: 11876709
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nocturnal gastric acidity pattern in gastro-oesophageal reflux disease with or without oesophagitis.
    Sozzi M; Valentini M; Poletti M; Bertolissi E; Serraino D; Bovero E; De Iaco F
    Ital J Gastroenterol; 1995; 27(8):413-8. PubMed ID: 8775466
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.